Irbesartan
- Product NDC
- 68180-410
- 11-digit product format
- 681800410
- Labeler code
- 68180
- Product ID
- 68180-410_58ed0a7a-78d3-47e3-95f6-ee4d1dd128bf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA201531
- Marketing category
- ANDA
- Marketing start
- 2012-10-23
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN
- Active strength
- 75 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 68180-410 | D | Discontinued by firm | 2026-08-11 | ||
| excluded package | package | 68180-410 | 68180-410-06 | D | Discontinued by firm | 2026-08-11 | |
| excluded package | package | 68180-410 | 68180-410-09 | D | Discontinued by firm | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68180-410-09 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 68180-410-06 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68180-410-09 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 68180-410-06 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68180-410-09 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 68180-410-06 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68180-410-09 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 68180-410-06 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68180-410-09 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 68180-410-06 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68180-410-09 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 68180-410-06 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68180-410-09 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 68180-410-06 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68180-410-09 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 68180-410-06 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68180-410-09 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 68180-410-06 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 68180-410-09 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 68180-410-06 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 68180-410-09 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 68180-410-06 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 68180-410-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 68180-410-06 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201531-001 | IRBESARTAN | IRBESARTAN | 75MG | TABLET / ORAL | 2012-10-15 | ||
| A201531-002 | IRBESARTAN | IRBESARTAN | 150MG | TABLET / ORAL | 2012-10-15 | ||
| A201531-003 | IRBESARTAN | IRBESARTAN | 300MG | TABLET / ORAL | 2012-10-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | 2012-10-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | 2012-10-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | 2012-10-15 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | 2012-10-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | 2012-10-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | 2012-10-15 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-002 | IRBESARTAN | 150MG | TABLET / ORAL | AB | 2012-10-15 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-003 | IRBESARTAN | 300MG | TABLET / ORAL | AB | 2012-10-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A201531-001 | IRBESARTAN | 75MG | TABLET / ORAL | AB | 2012-10-15 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-08-23 18:47 UTC | 2025-08 | A201531-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201531-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201531-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201531-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201531-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201531-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A201531-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A201531-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A201531-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A201531-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A201531-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A201531-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A201531-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A201531-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A201531-002 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A201531-003 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201531-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201531-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201531-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A201531-001 | AB | 1 | 5d02ea3f76ae… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 34942a29-de4f-d63c-7755-ba18fe1411a0 | Product name | 6 | 20180619 |
| a7349398-661d-d9fc-46df-7e128bbd61d9 | Product name | 5 | 20171113 |
| e0eeb018-194e-4b70-a57d-bac47a97b8ea | Product name | 1 | 20160825 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-410-06 | Irbesartan | 30 in 1 BOTTLE | TABLET | 30 | 17 | |
| 68180-410-09 | Irbesartan | 90 in 1 BOTTLE | TABLET | 90 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-410-06 | EA - Each | 68180-410 | a30e6baf-e7a6-465e-933e-851605f0c5e3 | 1 | 2013-02-13 |
| 68180-410-09 | EA - Each | 68180-410 | 2cc8c86a-5156-4c7a-b773-99a2aea1b242 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| IRBESARTAN | ACTIVE INGREDIENT | J0E2756Z7N | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| IRBESARTAN | ACTIVE MOIETY | J0E2756Z7N | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | IRBESARTAN TABLET [LUPIN PHARMACEUTICALS, INC.] | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Irbesartan | IRBESARTAN | Lupin Pharmaceuticals, Inc. | a7c093c2-3eef-4956-8a14-c36aada0304f | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 201531 ANDA201531 68180-410 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 200095 | irbesartan 150 MG Oral Tablet | PSN | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
| 200096 | irbesartan 300 MG Oral Tablet | PSN | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
| 200094 | irbesartan 75 MG Oral Tablet | PSN | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
| 200095 | irbesartan 150 MG Oral Tablet | SCD | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
| 200096 | irbesartan 300 MG Oral Tablet | SCD | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
| 200094 | irbesartan 75 MG Oral Tablet | SCD | a7c093c2-3eef-4956-8a14-c36aada0304f | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68180-410-06 | 68180041006 | 30 TABLET in 1 BOTTLE (68180-410-06) | 30 tablet | 2012-10-23 | 0000-00-00 | No | No | Current |
| 68180-410-09 | 68180041009 | 90 TABLET in 1 BOTTLE (68180-410-09) | 90 tablet | 2012-10-23 | 0000-00-00 | No | No | Current |